KMG Fiduciary Partners LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 3.2% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 15,902 shares of the healthcare conglomerate’s stock after selling 530 shares during the quarter. UnitedHealth Group comprises approximately 1.5% of KMG Fiduciary Partners LLC’s holdings, making the stock its 11th largest position. KMG Fiduciary Partners LLC’s holdings in UnitedHealth Group were worth $8,168,000 as of its most recent SEC filing.
Other large investors have also made changes to their positions in the company. Advocacy Wealth Management Services LLC lifted its position in shares of UnitedHealth Group by 75.8% during the 1st quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 25 shares during the last quarter. Cascade Investment Advisors Inc. lifted its position in shares of UnitedHealth Group by 100.0% during the 1st quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 30 shares during the last quarter. Evolution Advisers Inc. acquired a new position in shares of UnitedHealth Group during the 1st quarter worth about $38,000. Rise Advisors LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth about $38,000. Finally, Cordant Inc. acquired a new position in UnitedHealth Group in the 1st quarter valued at approximately $45,000. Institutional investors and hedge funds own 87.25% of the company’s stock.
Insider Buying and Selling
In related news, CAO Thomas E. Roos sold 465 shares of UnitedHealth Group stock in a transaction dated Friday, August 26th. The stock was sold at an average price of $542.37, for a total transaction of $252,202.05. Following the completion of the transaction, the chief accounting officer now owns 34,786 shares in the company, valued at $18,866,882.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, CAO Thomas E. Roos sold 465 shares of UnitedHealth Group stock in a transaction dated Friday, August 26th. The stock was sold at an average price of $542.37, for a total transaction of $252,202.05. Following the completion of the transaction, the chief accounting officer now owns 34,786 shares in the company, valued at $18,866,882.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Dirk C. Mcmahon sold 14,715 shares of the business’s stock in a transaction that occurred on Thursday, August 18th. The stock was sold at an average price of $543.32, for a total value of $7,994,953.80. Following the sale, the chief executive officer now owns 50,108 shares of the company’s stock, valued at approximately $27,224,678.56. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 139,051 shares of company stock worth $74,450,958. Company insiders own 0.40% of the company’s stock.
Analysts Set New Price Targets
UnitedHealth Group Stock Performance
UNH stock opened at $517.46 on Friday. The company has a market cap of $484.02 billion, a P/E ratio of 27.02, a price-to-earnings-growth ratio of 1.61 and a beta of 0.76. UnitedHealth Group Incorporated has a twelve month low of $383.12 and a twelve month high of $553.29. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.60. The business’s fifty day moving average is $530.11 and its 200-day moving average is $512.45.
UnitedHealth Group (NYSE:UNH – Get Rating) last issued its quarterly earnings data on Friday, July 15th. The healthcare conglomerate reported $5.57 EPS for the quarter, topping the consensus estimate of $5.24 by $0.33. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The business had revenue of $80.33 billion for the quarter, compared to the consensus estimate of $79.68 billion. During the same quarter last year, the business posted $4.70 EPS. The firm’s revenue was up 12.6% compared to the same quarter last year. Equities research analysts forecast that UnitedHealth Group Incorporated will post 21.85 EPS for the current year.
UnitedHealth Group Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Monday, September 12th were issued a dividend of $1.65 per share. This represents a $6.60 dividend on an annualized basis and a yield of 1.28%. The ex-dividend date was Friday, September 9th. UnitedHealth Group’s payout ratio is currently 34.46%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- What Steelcase’s Earnings Say About the Return to the Office?
- The Institutions Hold On To Darden Restaurants International
- Is The Golden Age Of Homebuilding Already Over?
- These 3 Big Dividend Payers Also Boast Strong Price Growth
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.